Kynam Capital Management »

Celldex Therapeutics shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $119M 3.0M 39.66
2023-09-30 $88M 3.2M 27.52
2023-06-30 $88M 2.6M 33.93
2023-03-31 $51M 1.4M 35.98
2022-12-31 $72M 1.6M 44.57
2022-09-30 $45M 1.6M 28.11
2022-06-30 $37M 1.4M 26.96
2022-03-31 $26M 753k 34.06
2021-12-31 $8.8M 227k 38.64